MDS Plus(Azacitidine tablets)
Therapeutic class: nucleoside metabolic inhibitor
Indication: Myelodysplastic Syndromes (MDS), Juvenile Myelomonocytic Leukemia (JMML)
- Lyophilized powder in 100 mg single dose vials.
- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by the physician
